David A. Largaespada

B-MoGen Biotechnologies, Inc. provides gene editing solutions for antibody validation, human disease research, gene transfer, and mitochondrial DNA editing. It offers custom vector generation services that include multi-gene expression vectors that are delivered via the proven sleeping beauty transposon system; and custom gene targeting vectors. The company was founded by David A. Largaespada and Branden S. Moriarity in 2015 and is headquartered in Minneapolis, MN.

Luminary Therapeutics, Inc. provides biotechnology services. The company was founded by Jeff Liter, David Largaespada, Beau Webber and Branden Moriarity in 2019 and is headquartered in Minneapolis, MN.

Recombinetics, Inc. operates as a gene editing technology company with a platform in therapeutics development. It uses genetic technologies to improve the health of people, animals, and the environment. The firms offers transplantable cells, tissues and organs for patients, accelerating drug, device therapy, and animal health, welfare and sustainability services. Recombinetics was founded by Scott C. Fahrenkrug in 2008 and is headquartered in Eagan, MN.

Makana Therapeutics, Inc. engages in human transplantation of cells, tissues and organs. The firm focuses on simplified genetics and optimized pig cloning techniques. The company was founded by Joe Tector in 2009 and is headquartered in Miami, FL.

Discovery Genomics, Inc. provides gene therapy tools to cure diseases. It discover gene functions and deliver safe, long-lasting gene therapy. The firm's products include SB Therapeutics Gene Delivery System and Licenses. The company was founded by R. Scott McIvor, Perry B. Hackett, Stephen C. Ekker, and David A. Largaespada in 2000 and is headquartered in Minneapolis, MN.